Vincerx Pharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
Vincerx Pharma, a biopharmaceutical company, announced its participation in a fireside chat at the 2021 Wells Fargo Virtual Healthcare Conference on September 9, 2021, at 4:40 PM Eastern Time. This event will focus on addressing unmet medical needs in cancer treatment. The presentation will be available via a live webcast and archived for 90 days on the company's website. Vincerx, leveraging its partnership with Bayer, is advancing several drug programs, including innovative antibody-drug conjugates.
- None.
- None.
PALO ALTO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that Vincerx’s management team will participate in a fireside chat at the 2021 Wells Fargo Virtual Healthcare Conference, to be held September 9-10, 2021.
| Vincerx Fireside Chat Details | ||
| Date: | Thursday, September 9, 2021 | |
| Time: | 4:40 PM Eastern Time | |
| Webcast: | https://kvgo.com/wells-fargo/vincerx-pharma-inc-sept-2021 | |
The presentation will be webcast live and archived for 90 days in the Investors section of the Company’s website.
About Vincerx Pharma, Inc.
Vincerx Pharma, Inc. (“Vincerx”) is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation platform, which includes next-generation antibody-drug conjugates and innovative small molecule drug conjugates.
Contact Information
Bruce Mackle
LifeSci Advisors, LLC
646-889-1200
bmackle@lifesciadvisors.com
FAQ
When is Vincerx participating in the Wells Fargo Virtual Healthcare Conference?
What time is Vincerx's fireside chat scheduled?
How can I watch Vincerx's presentation at the conference?
What is Vincerx Pharma's focus in oncology?
What is included in Vincerx's current pipeline?
